|
|
| | 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)- Basic information |
| Product Name: | 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)- | | Synonyms: | 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)-;Dyrk1A-IN-10 | | CAS: | 2891824-14-7 | | MF: | C22H21ClN2O2 | | MW: | 380.87 | | EINECS: | | | Product Categories: | | | Mol File: | 2891824-14-7.mol | ![2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)- Structure](CAS/20240320/GIF/2891824-14-7.gif) |
| | 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)- Chemical Properties |
| Boiling point | 630.6±55.0 °C(predicted) | | density | 1.287±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 16.94±0.40(predicted) |
| | 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)- Usage And Synthesis |
| Uses | Dyrk1A-IN-10 (compound B4) is a DYRK1A inhibitor with antidiabetic activity. Dyrk1A-IN-10 can promote pancreatic β-cell proliferation, increase insulin secretion, and lower blood sugar[1]. | | References | [1] Li Guan, et al. "Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes." Bioorganic Chemistry (2024): 107676. DOI:10.1016/j.bioorg.2024.107676 |
| | 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1,3,4,9-tetrahydro-6-methoxy-1-methyl-2H-pyrido[3,4-b]indol-2-yl)-, (2E)- Preparation Products And Raw materials |
|